|
||||||||||||||||||
|
|
||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe eBioA1 monoclonal antibody reacts with human CD39 also known as ENTPD1- ectonucleoside triphosphate diphosphohydrolase 1 or NTPDase. CD39 is an integral membrane protein with two transmembrane domains and exists as a homotetramer. It is the most prominent ectoenzyme of the immune system. The function of CD39 is to effectively remove toxic extracellular ATP by converting it to ADP or AMP. CD39 is thought to work together with CD73 to hydrolyze ATP and has been well characterized on langerhan cells. Expression of CD39 is originally identified on activated lymphocytes. Expression is also found on a subset of T cells, B cells and dendritic cells with weak staining on monocytes and granulocytes. Recently CD39 and CD73 have been found on regulatory T cells specifically the effector/memory like T cells. Functionally CD39 may allow Tregs to enter inflamed areas where high levels of ATP are present. Expression of Foxp3+ Cd4 positives cells range from 25-45% CD25+/CD39+ which his consistent with the findings of Borsellino et al. Applications ReportedFor research use only, not for diagnostic or therapeutic use. This eBioA1 (A1) antibody has been reported for use in flow cytometric analysis, and immunohistochemical staining. Applications TestedThis eBioA1 (A1) antibody has been tested by flow cytometric analysis of nomral human peripheral blood cells. This can be used at less than or equal to 0.25 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. References
Aversa GG., M.G. Suranyi, J.A. Waugh, A.G. Bishop, B.M. Hall. 1988. Detection of a Late Lymphocyte Activation Marker by A1, a New Monoclonal Antibody. Transplant Proc. 20(1):49-52. Aversa GG., J.A. Waugh, G.A. Bishop, B.M. Hall. 1989. Use of Monoclonal Antibodies to Study in vivo and in vitro-activated Lymphocytes. Transplant Proc. 21(1):349-50. Stockl J., O. Majdic, G. Fischer, D. Maurer, W. Knapp. 2001. Monomorphic Molecules Function as Additional Recognition Structures on Haptenated Target Cells for HLA-A1-Restricted, Hapten-Specific CTL. J. Immunol. 167L:2724-2733 Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Hopner S, Centonze D, Bernardi G, Dell'acqua ML, Rossini PM, Battistini L, Rotzschke O, Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007 Apr 20; [Epub ahead of print] Lyck L, Dalmau I, et al. 2008. Immunohistochemical markers for quantitative studies of neurons and glia in human neocortex. J Histochem Cytochem. 56(3):201-21. (A1, IHC frozen, PubMed) Related ProductsCat. 11-4011 FITC Anti-Mouse IgG Cat. 13-4013 Biotin Anti-Mouse IgG (clone Polyclonal) Cat. 11-4317 Streptavidin-FITC (Fluorescein isothiocyanate) Cat. 12-4317 Streptavidin-PE (Phycoerythrin) Cat. 17-4317 Streptavidin Allophycocyanin (SA-APC) Cat. 14-4714 Affinity Purified Mouse IgG1, K Isotype Control |
||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |